Do you have adult patients living with generalized anxiety disorder?

A Phase 3 study evaluating the efficacy and safety of investigational MM120 (100 μg) versus placebo in adults with generalized anxiety disorder in the United States (U.S.)

A Phase 3 study evaluating the efficacy and safety of investigational MM120 (100 μg and 50 μg) versus placebo in adults with generalized anxiety disorder in the United States (U.S.) and Europe